Latest Cancer News

Kisqali® Improves Outcomes of Premenopausal Women with HR+/HER2- Advanced Breast Cancer (12-12-2017)
It was announced today that results from the Phase III MONALEESA-7 trial evaluating Kisqali® (ribociclib) in combination endocrine-based therapy in premenopausal or perimenopausal women with hormone-receptor... Continue Reading

Keytruda Immunotherapy Shows Promise for Patients With Herceptin-resistant Breast Cancer (12-12-2017)
A combination of Keytruda (pembrolizumab) and Herceptin (trastuzumab), tested in patients with Herceptin-resistant advanced HER2-positive breast cancer, was well tolerated and had clinical benefit in patients... Continue Reading

FDA and CMS Collaborate to Make Novel Cancer Biomarker Test Available (12-7-2017)
The U.S. Food and Drug Administration (FDA) has approved the F1CDx biomarker test designed to detect mutations in 324 genes and two genomic signatures in cancer patients. In a truly collaborative effort... Continue Reading

More Cancer News

Locations

 
 

The Center At Boca Raton
701 NW 13th St.
2nd Floor
Boca Raton, FL 33486
TEL: (561) 955-6400
FAX: (561) 750-7662

 
 
 

The Center At Delray Beach
6282 Linton Blvd.
Delray Beach, Florida 33484
TEL: (561) 495-8307
FAX: (561) 495-6422

 
 
 
Click here for the Lynn Cancer Institute